213 related articles for article (PubMed ID: 20185186)
1. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
[TBL] [Abstract][Full Text] [Related]
2. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
3. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
[TBL] [Abstract][Full Text] [Related]
4. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy systems using proton and carbon beams.
Jongen Y
Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
[TBL] [Abstract][Full Text] [Related]
6. Particle radiation therapy using proton and heavier ion beams.
Schulz-Ertner D; Tsujii H
J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
[TBL] [Abstract][Full Text] [Related]
7. Examination of GyE system for HIMAC carbon therapy.
Kanai T; Matsufuji N; Miyamoto T; Mizoe J; Kamada T; Tsuji H; Kato H; Baba M; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):650-6. PubMed ID: 16414376
[TBL] [Abstract][Full Text] [Related]
8. Medical physics aspects of particle therapy.
Jäkel O
Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
[TBL] [Abstract][Full Text] [Related]
9. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
[TBL] [Abstract][Full Text] [Related]
10. Neutron production in tissue-like media and shielding materials irradiated with high-energy ion beams.
Gudowska I; Kopec M; Sobolevsky N
Radiat Prot Dosimetry; 2007; 126(1-4):652-6. PubMed ID: 17504751
[TBL] [Abstract][Full Text] [Related]
11. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390
[TBL] [Abstract][Full Text] [Related]
12. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
[TBL] [Abstract][Full Text] [Related]
13. The radiobiological effectiveness of carbon-ion beams on growing neurons.
Al-Jahdari WS; Suzuki Y; Yoshida Y; Hamada N; Shirai K; Noda SE; Funayama T; Sakashita T; Kobayashi Y; Saito S; Goto F; Nakano T
Int J Radiat Biol; 2009 Aug; 85(8):700-9. PubMed ID: 19637081
[TBL] [Abstract][Full Text] [Related]
14. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.
Tilly N; Johansson J; Isacsson U; Medin J; Blomquist E; Grusell E; Glimelius B
Phys Med Biol; 2005 Jun; 50(12):2765-77. PubMed ID: 15930601
[TBL] [Abstract][Full Text] [Related]
15. PET monitoring of cancer therapy with 3He and 12C beams: a study with the GEANT4 toolkit.
Pshenichnov I; Larionov A; Mishustin I; Greiner W
Phys Med Biol; 2007 Dec; 52(24):7295-312. PubMed ID: 18065840
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II clinical trials of carbon ion therapy for prostate cancer.
Akakura K; Tsujii H; Morita S; Tsuji H; Yagishita T; Isaka S; Ito H; Akaza H; Hata M; Fujime M; Harada M; Shimazaki J;
Prostate; 2004 Feb; 58(3):252-8. PubMed ID: 14743464
[TBL] [Abstract][Full Text] [Related]
17. Low and high LET dose components in carbon beam.
Gudowska I; Kempe J; Sobolevsky N
Radiat Prot Dosimetry; 2006; 122(1-4):483-4. PubMed ID: 17151009
[TBL] [Abstract][Full Text] [Related]
18. Contribution of secondary particles to the dose in 12C radiotherapy and other heavy ion beams.
Jadrnícková I; Spurny F; Molokanov AG
Radiat Prot Dosimetry; 2007; 126(1-4):657-9. PubMed ID: 17504750
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions.
Wilkens JJ; Oelfke U
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):262-6. PubMed ID: 17935903
[TBL] [Abstract][Full Text] [Related]
20. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
